Abstract:Fibroblast growth factor-4 (FGF4) is a heparin-binding growth factor that is a member of the fibroblast growth factor family. Proteins of this family play a central role during prenatal development, postnatal growth, and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. We setup an ethane-dimethane sulfonate (EDS) depleted Leydig cell regeneration model in adult male Sprague Dawley rats and treated them via intratesticular injection of FGF4 (0, 10, and 100 ng/testis/day) from post-EDS day 14 to 27. We measured serum hormone levels, Leydig cell number, gene, and protein expression in vivo. We explored the effects of FGF4 treatment on stem Leydig cell proliferation and differentiation and progenitor/adult Leydig cell steroidogenesis in vitro. FGF4 increased serum testosterone levels without affecting the levels of luteinizing hormone and follicle-stimulating hormone at 100 ng/testis on post-EDS day 28 in vivo. FGF4 increased Leydig cell number at 10 and 100 ng/mg without affecting Sertoli cell number and down-regulated the expression of Leydig cell genes (Lhcgr, Star, Cyp11a1, Hsd3b1, Cyp17a1, Hsd17b1, Insl3, and Nr5a1) per se and their proteins in vivo. FGF4 also lowered medium testosterone levels and down-regulated the expression of Leydig cell genes (Lhcgr, Scarb1, Star, Cyp11a1, Cyp17a1, and Hsd17b3) but increased EdU incorporation into stem Leydig cells at 10 or 100 ng/ml in vitro. FGF4 inhibited steroidogenesis at ³ 1 ng/ml. In conclusion, FGF4 stimulated stem Leydig cell proliferation but blocked their differentiation. In brief: FGF 4 inhibits differentiation but stimulates proliferation of rat stem Leydig cells

Fibroblast Growth Factor 4 Inhibits Differentiation but Stimulates Proliferation of Rat Stem Leydig Cells